Abstract
Optical coherence tomography (OCT) provides higher resolution intravascular imaging and allows detailed evaluations of stent implantation sites post-percutaneous coronary intervention (PCI). Coronary angioscopy (CAS) can evaluate the vascular response after drug-eluting stent (DES) implantation. The post-PCI OCT findings that are associated with the CAS 1-year vascular response have not been known. We enrolled 168 lesions from 119 patients who underwent OCT-guided PCI using DES and follow-up CAS observation at 1 ± 0.5 year from August 2012 to December 2019. Outcome measures were sufficient neointimal coverage (NIC) defined as stent struts embedded in the neointima, subclinical intrastent thrombus, and vulnerable stented segments defined as those with angioscopic yellow or intensive yellow color 1 year after PCI. We identified the post-PCI OCT findings associated with these CAS findings. Sufficient NIC, subclinical intrastent thrombus, and vulnerable stented segment were detected in 85 lesions (51%), 47 lesions (28%), and 54 lesions (32%), respectively. A multivariate analysis demonstrated that malapposed struts were negatively associated with sufficient NIC (odds ratio 0.87; 95% CI 0.76–0.99; p = 0.029). However, no specific OCT findings immediately after PCI were associated with subclinical intrastent thrombus or vulnerable stented segment. Malapposition immediately after PCI was negatively associated with sufficient NIC at 1 year even without associations between post-PCI OCT findings and subclinical intrastent thrombus or vulnerable stented segment.
Similar content being viewed by others
Data availability
Our study data will not be made available to other researchers for purposes of reproducing the results, due to institutional review board restrictions.
Abbreviations
- CAS:
-
Coronary angioscopy
- CRP:
-
C-reactive protein
- DES:
-
Drug-eluting stent
- ISA:
-
Incomplete stent apposition
- LAD:
-
Left anterior descending
- NIC:
-
Neointimal coverage
- OCT:
-
Optical coherence tomography
- PCI:
-
Percutaneous coronary intervention
- SED:
-
Stent edge dissection
- ST:
-
Stent thrombosis
References
Tada T, Byrne RA, Simunovic I, King LA, Cassese S, Joner M, et al. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: results from a registry of 18,334 patients. J Am Coll Cardiol Intervent. 2013;6:1267–74.
Nakazawa G, Finn AV, Vorpahl M, Ladich ER, Kolodgie FD, Virmani R. Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents. J Am Coll Cardiol. 2011;57:390–8.
Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007;115:2435–41.
Guagliumi G, Sirbu V, Musumeci G, Gerber R, Biondi-Zoccai G, Ikejima H, et al. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. J Am Coll Cardiol Intervent. 2012;5:12–20.
Ishihara T, Awata M, Fujita M, Watanabe T, Iida O, Ishida Y, et al. Very late stent thrombosis 5 years after implantation of a sirolimus-eluting stent observed by angioscopy and optical coherence tomography. J Am Coll Cardiol Intervent. 2013;6:e28–30.
Inoue T, Shinke T, Otake H, Nakagawa M, Hariki H, Osue T, et al. Neoatherosclerosis and mural thrombus detection after sirolimus-eluting stent implantation. Circ J. 2014;78:92–100.
Schwartz RS. Pathophysiology of restenosis: Interaction of thrombosis, hyperplasia, and/or remodeling. Am J Cardiol. 1998;81:14E-17E.
Awata M, Kotani J, Uematsu M, Morozumi T, Watanabe T, Onishi T, et al. Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents. Circulation. 2007;116:910–6.
Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, et al. Implication of plaque color classification for assessing plaque vulnerability: a coronary angioscopy and optical coherence tomography investigation. J Am Coll Cardiol Intervent. 2008;1:74–80.
Mitsutake Y, Ueno T, Yokoyama S, Sasaki K, Sugi Y, Toyama Y, et al. Coronary endothelial dysfunction distal to stent of first-generation drug-eluting stents. J Am Coll Cardiol Intervent. 2012;5:966–73.
Räber L, Mintz GS, Koskinas KC, Johnson TW, Holm NR, Onuma Y, et al. Clinical use of intracoronary imaging. Part 1: Guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J. 2018;39:3281–300.
Kume T, Okura H, Miyamoto Y, Yamada R, Saito K, Tamada T, et al. Natural history of stent edge dissection, tissue protrusion and incomplete stent apposition detectable only on optical coherence tomography after stent implantation—preliminary observation. Circ J. 2012;76:698–703.
Ozaki Y, Okumura M, Ismail TF, Naruse H, Hattori K, Kan S, et al. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study. Eur Heart J. 2010;31:1470–6.
Gutierrez-Chico J, Wykrzykowska JJ, Nuesch E, van Geuns RJ, Koch K, Koolen JJ, et al. Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography. Circ Cardiovasc Interv. 2012;5:20–9.
Gutierrez-Chico JL, Regar E, Nuesch E, Okamura T, Wykrzykowska J, di Mario C, et al. Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents. Circulation. 2011;124:612–23.
Sanuki Y, Sonoda S, Muraoka Y, Shimizu A, Kitagawa M, Takami H, et al. Contribution of poststent irregular protrusion to subsequent in-stent neoatherosclerosis after the second-generation drug-eluting stent implantation. Int Heart J. 2018;59:307–14.
Soeda T, Uemura S, Park S-J, Jang Y, Lee S, Cho J-M. Incidence and clinical significance of poststent optical coherence tomography findings: one-year follow-up study from a multicenter registry. Circulation. 2015;132:1020–9.
Fujii K, Kubo T, Otake H, Nakazawa G, Sonoda S, Hibi K, et al. Expert consensus statement for quantitative measurement and morphological assessment of optical coherence tomography. Cardiovasc Interv Ther. 2020;35:13–8.
Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, et al. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol. 2006;47:2108–11.
Mitsutake Y, Yano H, Ishihara T, Matsuoka H, Ueda Y, Ueno T. Consensus document on the standard of coronary angioscopy examination and assessment from the Japanese Association of Cardiovascular Intervention and Therapeutics. Cardiovasc Interv Ther. 2021. https://doi.org/10.1007/s12928-021-00770-x.
Ishihara T, Tsujimura T, Okuno S, Iida O, Asai M, Masuda M, et al. Early- and middle-phase arterial repair following bioresorbable- and durable-polymer drug-eluting stent implantation: an angioscopic study. Int J Cardiol. 2019;285:27–31.
Okuno S, Ishihara T, Iida O, Asai M, Masuda M, Okamoto S, et al. Association of subclinical intrastent thrombus detected 9 months after implantation of 2nd-generation drug-eluting stent with future major adverse cardiac events—a coronary angioscopic study. Circ J. 2018;82:2299–304.
Nakamura D, Attizzani GF, Toma C, Sheth T, Wang W, Soud M, et al. Failure mechanisms and neoatherosclerosis patterns in very late drug-eluting and bare-metal stent thrombosis. Circ Cardiovasc Interv. 2016;9: e003785.
Taniwaki M, Radu MD, Zaugg S, Amabile N, Garcia-Garcia HM, Yamaji K, et al. Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography. Circulation. 2016;133:650–60.
Lee SY, Ahn JM, Mintz GS, Hur SH, Choi SY, Kim SW, et al. Characteristics of earlier versus delayed presentation of very late drug-eluting stent thrombosis: an optical coherence tomographic study. J Am Heart Assoc. 2017;6: e005386.
Lee SY, Kim JS, Yoon HJ, Hur SH, Lee SG, Kim JW, et al. Early strut coverage in patients receiving drug-eluting stents and its implications for dual antiplatelet therapy: a randomized trial. J Am Coll Cardiol Imaging. 2018;11:1810–9.
Sakai S, Sato A, Hoshi T, Hiraya D, Watabe H, Ieda M. In vivo evaluation of tissue protrusion by using optical coherence tomography and coronary angioscopy immediately after stent implantation. Circ J. 2020;84:2235–43.
Miyoshi T, Kawakami H, Seike F, Oshita A, Matsuoka H. Relationship between yellow plaque grade and tissue protrusion after stent implantation: a coronary angioscopy study. J Cardiol. 2017;70:342–5.
Higo T, Ueda Y, Oyabu J, Okada K, Nishio M, Hirata A, et al. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study. J Am Coll Cardiol Imaging. 2009;2:616–24.
Akazawa Y, Matsuo K, Ueda Y, Nishio M, Hirata A, Asai M, et al. Atherosclerotic change at one year after implantation of endeavor zotarolimus-eluting stent vs everolimus-eluting stent. Circ J. 2014;78:1428–36.
Otsuka F, Vorpahl M, Nakano M, Foerst J, Newell JB, Sakakura K, et al. Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans. Circulation. 2014;129:211–23.
Ueda Y, Matsuo K, Nishimoto Y, Sugihara R, Hirata A, Nemoto T, et al. In-stent yellow plaque at 1 year after implantation is associated with future event of very late stent failure: The DESNOTE Study (Detect the Event of Very late Stent Failure From the Drug-Eluting Stent Not Well Covered by Neointima Determined by Angioscopy). J Am Coll Cardiol Intv. 2015;8:814–21.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
O. Iida has received remuneration from Boston Scientific Japan. T. Mano has received a research grant from Abbott Medical Japan. The remaining authors have no disclosures to report.
IRB information
Name of the ethics committee: The Medical Ethics Committee of Kansai Rosai Hospital; Reference number: 18D060g.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Higashino, N., Ishihara, T., Iida, O. et al. Identification of post-procedural optical coherence tomography findings associated with the 1-year vascular response evaluated by coronary angioscopy. Cardiovasc Interv and Ther 38, 86–95 (2023). https://doi.org/10.1007/s12928-022-00880-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12928-022-00880-0